Learning Tracks

Healthcare practitioners have been prescribing, dispensing, and administering biosimilars for more than a decade, yet knowledge gaps persist regarding biosimilar use, interchangeability, switching, and patient communication. As biosimilars expand into new therapeutic areas, ongoing education remains essential.

Panelists from the FDA, academia, and healthcare professional organizations will discuss educational needs across the professional continuum, current resources and gaps, and strategies to support lifelong learning. The session will also explore the roles of regulators, associations, employers, academic institutions, and manufacturers in developing and delivering biosimilar education.

Learning Objectives:

• Describe the educational needs and range of healthcare practitioners involved in prescribing, dispensing, administering, and influencing the use of biosimilars.
• Identify biosimilar educational resources across the professional continuum, including academic, FDA, continuing education, and employer-based initiatives.
• Identify resources that address common misconceptions and support the practical application of biosimilars, including interchangeability, switching, and patient communication.
• Evaluate knowledge gaps and stakeholder approaches for advancing lifelong learning and improving biosimilar competency across healthcare settings.